Similarly, the commonly targeted genes by all three oncofusion proteins show higher expression patterns in AML-subtypes as compared to CD34+ cells and enrich biological pathways crucial for leukemogenesis. This evidence concerns the gene CD34 and acute myeloid leukemia.